These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36564103)

  • 21. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
    Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
    J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The underutilisation of dual antiplatelet therapy in acute coronary syndrome.
    Anastasius M; Lau JK; Hyun K; D'Souza M; Patel A; Rankin J; Walters D; Juergens C; Aliprandi-Costa B; Yan AT; Goodman SG; Chew D; Brieger D
    Int J Cardiol; 2017 Aug; 240():30-36. PubMed ID: 28476519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology of gastrointestinal bleeding in patients on dual antiplatelet therapy.
    Shaukat A; Waheed S; Alexander E; Washko D; Dawn B; Olyaee M; Gupta K
    J Dig Dis; 2018 Feb; 19(2):66-73. PubMed ID: 29314627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel and proton pump inhibitors--where do we stand in 2012?
    Drepper MD; Spahr L; Frossard JL
    World J Gastroenterol; 2012 May; 18(18):2161-71. PubMed ID: 22611308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis?
    Trenk D
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):1-10. PubMed ID: 19203527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events.
    Dobesh PP; Finks SW; Trujillo TC
    Clin Ther; 2020 Oct; 42(10):2084-2097. PubMed ID: 32873416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing co-administration of clopidogrel and proton pump inhibitors in acute coronary syndromes.
    Vassiliou V; Silva A; Kavvoura F; Schofield R; Rowlands DB
    J R Coll Physicians Edinb; 2012 Mar; 42(1):21-3. PubMed ID: 22441058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; Rodríguez LA
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):378-86. PubMed ID: 25501499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review.
    Almufleh A; Ramirez FD; So D; Le May M; Chong AY; Torabi N; Hibbert B
    Cardiology; 2018; 140(2):115-123. PubMed ID: 29966126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance.
    de Groot NL; van Haalen HG; Spiegel BM; Laine L; Lanas A; Focks JJ; Siersema PD; van Oijen MG
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):341-57. PubMed ID: 23417566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel and PPI interaction: clinically relevant or not?
    Harrison RW; Mahaffey KW
    Curr Cardiol Rep; 2012 Feb; 14(1):49-58. PubMed ID: 22090195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    Kamran H; Jneid H; Kayani WT; Virani SS; Levine GN; Nambi V; Khalid U
    JAMA; 2021 Apr; 325(15):1545-1555. PubMed ID: 33877270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
    Kim BK; Hong SJ; Cho YH; Yun KH; Kim YH; Suh Y; Cho JY; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon H; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
    JAMA; 2020 Jun; 323(23):2407-2416. PubMed ID: 32543684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
    Ribera A; Ferreira-Gonzalez I; Marsal JR; Oristrell G; Faixedas MT; Rosas A; Tizón-Marcos H; Rojas S; Labata C; Cardenas M; Homs S; Tomas-Querol C; Garcia-Picart J; Gomez-Hospital JA; Pijoan JI; Masotti M; Mauri J; Garcia Dorado D;
    BMJ Open; 2019 Jul; 9(7):e028114. PubMed ID: 31340964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial.
    Verdoia M; Suryapranata H; Damen S; Camaro C; Benit E; Barbieri L; Rasoul S; Liew HB; Polad J; Ahmad WAW; Zambahari R; Lalmand J; van der Schaaf RJ; Koh TH; Timmermans P; Dilling-Boer D; Veenstra LF; Van't Hof AWJ; Lee SWL; Roolvink V; Ligtenberg E; Postma S; Kolkman EJJ; Brouwer MA; Kedhi E; De Luca G
    J Thromb Thrombolysis; 2021 Oct; 52(3):797-807. PubMed ID: 33847862
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.